Cargando…

Human microbiota associated IL-10(−/−) mice: A valuable enterocolitis model to dissect the interactions of Campylobacter jejuni with host immunity and gut microbiota

Secondary abiotic (SAB) IL-10(−/−) mice constitute a valuable Campylobacter jejuni-induced enterocolitis model. Given that the host-specific gut microbiota plays a key role in susceptibility of the vertebrate host towards or resistance against enteropathogenic infection, we surveyed immunopathologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shayya, Nizar W., Foote, Minnja S., Langfeld, Luis Q., Du, Ke, Bandick, Rasmus, Mousavi, Soraya, Bereswill, Stefan, Heimesaat, Markus M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Akadémiai Kiadó 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869866/ https://www.ncbi.nlm.nih.gov/pubmed/36633627 http://dx.doi.org/10.1556/1886.2022.00024

Ejemplares similares

Campylobacter jejuni infection induces acute enterocolitis in IL-10(-/-) mice pretreated with ampicillin plus sulbactam
por: Heimesaat, Markus M., et al.
Publicado: (2022)

Less Pronounced Immunopathological Responses Following Oral Butyrate Treatment of Campylobacter jejuni-Infected Mice
por: Du, Ke, et al.
Publicado: (2022)

Vitamin C alleviates acute enterocolitis in Campylobacter jejuni infected mice
por: Mousavi, Soraya, et al.
Publicado: (2020)

Preclinical Evaluation of Oral Urolithin-A for the Treatment of Acute Campylobacteriosis in Campylobacter jejuni Infected Microbiota-Depleted IL-10(−/−) Mice
por: Mousavi, Soraya, et al.
Publicado: (2020)

Treatment with the Probiotic Product Aviguard(®) Alleviates Inflammatory Responses during Campylobacter jejuni-Induced Acute Enterocolitis in Mice
por: Heimesaat, Markus M., et al.
Publicado: (2021)

Therapeutic Oral Application of Carvacrol Alleviates Acute Campylobacteriosis in Mice Harboring a Human Gut Microbiota
por: Foote, Minnja S., et al.
Publicado: (2023)

Oral application of carvacrol, butyrate, ellagic acid, and 2′-fucosyl-lactose to mice suffering from acute campylobacteriosis – Results from a preclinical placebo-controlled intervention study
por: Mousavi, Soraya, et al.
Publicado: (2023)

Immune-modulatory Properties of the Octapeptide NAP in Campylobacter jejuni Infected Mice Suffering from Acute Enterocolitis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Resveratrol Alleviates Acute Campylobacter jejuni Induced Enterocolitis in a Preclinical Murine Intervention Study
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Vitamin D in Acute Campylobacteriosis–Results From an Intervention Study Applying a Clinical Campylobacter jejuni Induced Enterocolitis Model
por: Mousavi, Soraya, et al.
Publicado: (2019)

Pituitary Adenylate Cyclase-Activating Polypeptide Alleviates Intestinal, Extra-Intestinal and Systemic Inflammatory Responses during Acute Campylobacter jejuni-induced Enterocolitis in Mice
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Murine Fecal Microbiota Transplantation Alleviates Intestinal and Systemic Immune Responses in Campylobacter jejuni Infected Mice Harboring a Human Gut Microbiota
por: Heimesaat, Markus M., et al.
Publicado: (2019)

Novel Clinical Campylobacter jejuni Infection Models Based on Sensitization of Mice to Lipooligosaccharide, a Major Bacterial Factor Triggering Innate Immune Responses in Human Campylobacteriosis
por: Mousavi, Soraya, et al.
Publicado: (2020)

Therapeutic Effects of Oral Application of Menthol and Extracts from Tormentil (Potentilla erecta), Raspberry Leaves (Rubus idaeus), and Loosestrife (Lythrum salicaria) during Acute Murine Campylobacteriosis
por: Bandick, Rasmus, et al.
Publicado: (2023)

Inflammatory Immune Responses and Gut Microbiota Changes Following Campylobacter coli Infection of IL-10(-/-) Mice with Chronic Colitis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Review of therapeutic options for infections with carbapenem-resistant Klebsiella pneumoniae
por: BANDICK, RASMUS G., et al.
Publicado: (2020)

Microbiota Composition and Immune Responses During Campylobacter Jejuni Infection in Conventionally Colonized IL-10(–/–) Mice Lacking Nucleotide Oligomerization Domain 2
por: Heimesaat, Markus M., et al.
Publicado: (2016)

Iron Deprivation by Oral Deferoxamine Application Alleviates Acute Campylobacteriosis in a Clinical Murine Campylobacter jejuni Infection Model
por: Bereswill, Stefan, et al.
Publicado: (2022)

Campylobacter jejuni Induces Acute Enterocolitis in Gnotobiotic IL-10(−/−) Mice via Toll-Like-Receptor-2 and -4 Signaling
por: Haag, Lea-Maxie, et al.
Publicado: (2012)

The Host-Specific Intestinal Microbiota Composition Impacts Campylobacter coli Infection in a Clinical Mouse Model of Campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Murine fecal microbiota transplantation lowers gastrointestinal pathogen loads and dampens pro-inflammatory immune responses in Campylobacter jejuni infected secondary abiotic mice
por: Heimesaat, Markus M., et al.
Publicado: (2019)

Vitamin E as promising adjunct treatment option in the combat of infectious diseases caused by bacterial including multi-drug resistant pathogens – Results from a comprehensive literature survey
por: HARTMANN, MINNJA S., et al.
Publicado: (2020)

Protease Activity of Campylobacter jejuni HtrA Modulates Distinct Intestinal and Systemic Immune Responses in Infected Secondary Abiotic IL-10 Deficient Mice
por: Schmidt, Anna-Maria, et al.
Publicado: (2019)

Toll-Like Receptor-4 Dependent Intestinal and Systemic Sequelae Following Peroral Campylobacter coli Infection of IL10 Deficient Mice Harboring a Human Gut Microbiota
por: Kløve, Sigri, et al.
Publicado: (2020)

Immunopathological properties of the Campylobacter jejuni flagellins and the adhesin CadF as assessed in a clinical murine infection model
por: Schmidt, Anna-Maria, et al.
Publicado: (2019)

The IL-23/IL-22/IL-18 axis in murine Campylobacter jejuni infection
por: Heimesaat, Markus M., et al.
Publicado: (2016)

Vitamin D Reverses Disruption of Gut Epithelial Barrier Function Caused by Campylobacter jejuni
por: Lobo de Sá, Fábia D., et al.
Publicado: (2021)

Intestinal Microbiota Shifts towards Elevated Commensal Escherichia coli Loads Abrogate Colonization Resistance against Campylobacter jejuni in Mice
por: Haag, Lea-Maxie, et al.
Publicado: (2012)

Peptidase PepP is a novel virulence factor of Campylobacter jejuni contributing to murine campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

The Role of IL-23, IL-22, and IL-18 in Campylobacter Jejuni Infection of Conventional Infant Mice
por: Heimesaat, Markus M., et al.
Publicado: (2016)

The role of serine protease HtrA in acute ulcerative enterocolitis and extra-intestinal immune responses during Campylobacter jejuni infection of gnotobiotic IL-10 deficient mice
por: Heimesaat, Markus M., et al.
Publicado: (2014)

Combination of organic acids benzoate, butyrate, caprylate, and sorbate provides a novel antibiotics-independent treatment option in the combat of acute campylobacteriosis
por: Du, Ke, et al.
Publicado: (2023)

The conundrum of colonization resistance against Campylobacter reloaded: The gut microbota composition in conventional mice does not prevent from Campylobacter coli infection
por: GENGER, CLAUDIA, et al.
Publicado: (2020)

Curcumin Mitigates Immune-Induced Epithelial Barrier Dysfunction by Campylobacter jejuni
por: Lobo de Sá, Fábia Daniela, et al.
Publicado: (2019)

Relapse of acute myocarditis associated with Campylobacter jejuni enterocolitis
por: Yaita, Shizuka, et al.
Publicado: (2020)

The Role of Gelatinases in Campylobacter Jejuni Infection of Gnotobiotic Mice
por: Alutis, Marie E., et al.
Publicado: (2015)

Campylobacter jejuni infection of conventionally colonized mice lacking nucleotide-oligomerization-domain-2
por: Bereswill, Stefan, et al.
Publicado: (2017)

Novel Murine Infection Models Provide Deep Insights into the “Ménage à Trois” of Campylobacter jejuni, Microbiota and Host Innate Immunity
por: Bereswill, Stefan, et al.
Publicado: (2011)

Amelioration of intestinal and systemic sequelae of murine Campylobacter jejuni infection by probiotic VSL#3 treatment
por: Ekmekciu, Ira, et al.
Publicado: (2017)

Interleukin-18 Mediates Immune Responses to Campylobacter jejuni Infection in Gnotobiotic Mice
por: Bereswill, Stefan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k8vvg0chmvvvnmigq095efh9f3